Dasom Kong
Overview
Explore the profile of Dasom Kong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Kong D, Kim N, Kim M, Kim H, Choi J, et al.
BMC Vet Res
. 2025 Feb;
21(1):115.
PMID: 40011929
Atopic dermatitis (AD) is a chronic and inflammatory disease. According to a recent study, administration of canine MSCs is a potential therapy for immunological diseases. However, most related studies involve...
2.
Park H, Kim C, Kong D, Heo S, Park H
Tissue Eng Regen Med
. 2025 Feb;
PMID: 39921820
Background: Vascular diseases, including atherosclerosis and thrombosis, are leading causes of morbidity and mortality worldwide, often resulting in vessel stenosis that impairs blood flow and leads to severe clinical outcomes....
3.
Kong D, Ryu J, Shin N, Lee S, Kim N, Kim H, et al.
Adv Healthc Mater
. 2024 Nov;
14(1):e2400919.
PMID: 39580678
As modeling of atherosclerosis requires recapitulating complex interactions with vasculature and immune cells, previous in vitro models have limitations due to their insufficient 3D vascular structures. However, induced pluripotent stem...
4.
Kim M, Ahn H, Kong D, Lee S, Kim D, Kang K
J Tissue Eng
. 2024 May;
15:20417314241248753.
PMID: 38725732
Solar ultraviolet (sUV) exposure is known to cause skin damage. However, the pathological mechanisms of sUV on hair follicles have not been extensively explored. Here, we established a model of...
5.
Kong D, Kwon D, Moon B, Kim D, Kim M, Choi J, et al.
Biomed Pharmacother
. 2024 Mar;
174:116436.
PMID: 38508081
In cancer immunotherapy, chimeric antigen receptors (CARs) targeting specific antigens have become a powerful tool for cell-based therapy. CAR-natural killer (NK) cells offer selective anticancer lysis with reduced off-tumor toxicity...
6.
Kim M, Kong D, Han M, Roh K, Koo H, Lee S, et al.
Vet Res Commun
. 2023 Jul;
47(4):2055-2070.
PMID: 37421548
Mesenchymal stem cells (MSCs) are a promising tool for treating immune disorders. However, the immunomodulatory effects of canine MSCs compared with other commercialized biologics for treating immune disorders have not...
7.
Kong D, Park K, Kim D, Kim N, Lee S, Shin N, et al.
Cell Death Discov
. 2023 Jan;
9(1):32.
PMID: 36697403
A correlation between COVID-19 and Alzheimer's disease (AD) has been proposed recently. Although the number of case reports on neuroinflammation in COVID-19 patients has increased, studies of SARS-CoV-2 neurotrophic pathology...
8.
Lee S, Choi H, Shin N, Kong D, Kim N, Kim H, et al.
Cell Death Discov
. 2022 Apr;
8(1):153.
PMID: 35368019
Alzheimer's disease (AD) is one of the progressive neurodegenerative diseases characterized by β-amyloid (Aβ) production and Phosphorylated-Tau (p-Tau) protein in the cerebral cortex. The precise mechanisms of the cause, responsible...
9.
Kook M, Lee S, Shin N, Kong D, Kim D, Kim M, et al.
Int J Stem Cells
. 2022 Feb;
15(1):85-94.
PMID: 35220294
Background And Objectives: Brain organoids have the potential to improve our understanding of brain development and neurological disease. Despite the importance of brain organoids, the effect of vascularization on brain...
10.
Lee S, Kwon D, Shin N, Kong D, Kim N, Kim H, et al.
Cell Death Discov
. 2022 Jan;
8(1):1.
PMID: 35013145
Mitochondrial dysfunction is associated with familial Alzheimer's disease (fAD), and the accumulation of damaged mitochondria has been reported as an initial symptom that further contributes to disease progression. In the...